Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Living Cell Technologies saluted by bioscience peers


Living Cell Technologies saluted by bioscience peers

Auckland New Zealand March 20: Living Cell Technologies (LCT) has been named as the New Zealand’s top bioscience company and Dr Doug Wilson as the Janssen Distinguished Biotechnologist at the 2013 NZBIO Conference Awards.


Dr Andrea Grant of LCT

Dr George Slim, CEO of NZBIO, says the judges rewarded LCT for taking a complex, world-first treatment technology over some very tough regulatory hurdles to show considerable promise in human trials.

“The company has a strong portfolio of follow on products and has recently entered into a partnership deal with a major international pharmaceutical company,” the judges said.

Dr Slim said it had been tough selecting the top bioscience company, because among the finalists there was a range of excellent businesses, all of which had different business models.

The top biotechnologist, Dr Doug Wilson, is a graduate from the University of Auckland medical school. He did post graduate research in London before starting an academic career in Auckland. In 1987 he changed tack and became NZ medical director of Boehringer Ingelheim in New Zealand.


Dr Doug Wilson

Dr Wilson rose to become the head of Boehringer Ingelheim Clinical Research Institute, overseeing all clinical research worldwide for the company. He then became head of medicine and regulatory affairs worldwide, based in Germany, overseeing all the research programmes for the company and all interactions with the European Medicines Evaluation Agency (EMEA).

NZBIO also salutes emerging talent in the bioscience sector. The emerging company of the year must be less than five-years-old and have a product pipeline and a development strategy, among other criteria. The young biotechnologist of the year is awarded to someone under 40-years-old whose work demonstrates the potential for future leadership in New Zealand’s bioeconomy.

The emerging company of the year was awarded to Biotelliga. The judges commented that Biotelliga shows strong links between its science, the industry sector and consumers’ needs in an important area of the New Zealand economy.

Biotelliga, which is based at Pukekohe near Auckland, develops and produces biological, sustainable, non-chemical based crop spray solutions for the effective management and control of pests and diseases in agriculture and horticulture.

The young biotechnologist for 2013 was awarded to Hywel Griffiths from Photonz, an Auckland-based company which produces the omega-3 fatty acid eicosapentaenoic acid (EPA) from its primary source, marine microalgae. EPA is a critical ingredient in regulated pharmaceutical products and medicinal foods addressing cardiovascular disease.

The judges commented that Dr Griffiths has gone from an outstanding record of doctoral and postdoctoral research in Europe to making a significant contribution to scale up and development of bioprocesses for a leading New Zealand company.

“Dr Griffiths is an acknowledged world leader in a complex area of science and has recruited and led an excellent team of scientists as the company grows rapidly,” the judges said.

Dr Slim says while there is plenty of young talent about and the emerging companies who were finalists were good companies, NZBIO is concerned that the pipeline of emerging bioscience companies is less than what it has been in the past 10 years.

NZBIO has been reviewing its past decade and says while the sector has got close to some goals outlined for it in 2003, like the rest of the world there has been a levelling out in the growth of the sector while governments realign their strategies and concentrate on “outputs”, often at the expense of supporting innovation and entrepreneurial ideas with world class potential.

“New Zealand’s innovation is celebrated internationally and its entrepreneurs have attracted foreign investment,” Dr Slim says. “With the limited pool of capital beyond the first couple of stages of development in New Zealand, it is vital for our companies to retain NZ support if they are to realise the potential of their technologies internationally.”

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Crown Accounts: Government Ekes Out Six-Month Surplus Of $9M

The New Zealand government eked out a tiny surplus in the first six months of the fiscal year as growth in domestic consumption lifted the goods and services tax take, while uncertainties over the Kaikoura earthquake costs meant expenses were less than expected. More>>

ALSO:

Almost 400 Jobs: Shock At Cadbury's Dunedin Factory Closure

Workers at Cadbury in Dunedin are reeling after learning this morning that the iconic Cadbury factory is to close, with the loss of almost 400 jobs... “The company had reported it was doing well and this has come out of the blue,” says Chas. More>>

ALSO:

Transport: Boards Of Inquiry For Auckland Roading Projects

Boards of Inquiry have been appointed to decide on two significant Auckland roading projects in a move which will get a decision by the end of the year, Environment Minister Dr Nick Smith and Conservation Minister Maggie Barry announced today. More>>

ALSO:

Three Months On: Quake Reciovery In Kaikōura And Elsewhere

Three months after the magnitude 7.8 earthquake on 14 November, encouraging recovery progress is being made in affected communities. More>>

ALSO:

Jetstar, Qantas For Govt Transport: Government Still In Talks With Air NZ

The government is still negotiating with national carrier Air New Zealand in a cross-agency air travel contract that will add a number of new airlines to the list of approved flyers. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news